Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Magnitude of Mycobacterium tuberculosis transmission among household and non-household contacts of TB patients.

Kato-Maeda M, Choi JC, Jarlsberg LG, Grinsdale JA, Higashi J, Kawamura LM, Osmond DH, Hopewell PC.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):433-440. doi: 10.5588/ijtld.18.0273.

PMID:
31064622
2.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
3.

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

Nahid P, Jarlsberg LG, Kato-Maeda M, Segal MR, Osmond DH, Gagneux S, Dobos K, Gold M, Hopewell PC, Lewinsohn DM.

PLoS One. 2018 May 22;13(5):e0195392. doi: 10.1371/journal.pone.0195392. eCollection 2018.

4.

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

Feng JY, Jarlsberg LG, Salcedo K, Rose J, Janes M, Lin SG, Osmond DH, Jost KC, Soehnlen MK, Flood J, Graviss EA, Desmond E, Moonan PK, Nahid P, Hopewell PC, Kato-Maeda M.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):766-773. doi: 10.5588/ijtld.16.0510. Epub 2017 May 16.

5.

Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.

Feng JY, Jarlsberg LG, Rose J, Grinsdale JA, Janes M, Higashi J, Osmond DH, Nahid P, Hopewell PC, Kato-Maeda M.

Int J Tuberc Lung Dis. 2017 May 1;21(5):509-516. doi: 10.5588/ijtld.16.0487.

PMID:
28399965
6.

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1522-1528. Review.

PMID:
27776595
7.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566.

8.

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.

9.

Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.

Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mason P, Hopewell PC.

Int J Tuberc Lung Dis. 2016 Jul;20(7):882-9. doi: 10.5588/ijtld.15.0696.

10.

Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital.

Iroezindu MO, Ofondu EO, Mbata GC, van Wyk B, Hausler HP, Dh A, Lynen L, Hopewell PC.

Ann Med Health Sci Res. 2016 Mar-Apr;6(2):120-8. doi: 10.4103/2141-9248.181837.

11.

Treatment of Tuberculosis. A Historical Perspective.

Murray JF, Schraufnagel DE, Hopewell PC.

Ann Am Thorac Soc. 2015 Dec;12(12):1749-59. doi: 10.1513/AnnalsATS.201509-632PS.

PMID:
26653188
12.

Giants in Chest Medicine: John F. Murray, MD.

Murray JF, Hopewell PC.

Chest. 2015 Nov;148(5):1123-1125. doi: 10.1378/chest.15-2005. No abstract available.

PMID:
26527434
13.

Reduced sensitivity of the QuantiFERON(®) test in diabetic patients with smear-negative tuberculosis.

Choi JC, Jarlsberg LG, Grinsdale JA, Osmond DH, Higashi J, Hopewell PC, Kato-Maeda M.

Int J Tuberc Lung Dis. 2015 May;19(5):582-8. doi: 10.5588/ijtld.14.0553.

PMID:
25868028
14.

Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients.

Metcalfe JZ, Makumbirofa S, Makamure B, Mutetwa R, Peñaloza RA, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P.

Eur Respir J. 2015 May;45(5):1504-6. doi: 10.1183/09031936.00214114. Epub 2015 Mar 18. No abstract available.

15.

Pulmonary specialty training to improve respiratory health in low- and middle-income countries. Needs and challenges.

Chakaya JM, Carter EJ, Hopewell PC.

Ann Am Thorac Soc. 2015 Apr;12(4):486-90. doi: 10.1513/AnnalsATS.201502-071PS.

PMID:
25714500
16.

Tuberculosis contact investigation in low- and middle-income countries: standardized definitions and indicators.

Fair E, Miller CR, Ottmani SE, Fox GJ, Hopewell PC.

Int J Tuberc Lung Dis. 2015 Mar;19(3):269-72. doi: 10.5588/ijtld.14.0512.

PMID:
25686131
17.

Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.

Metcalfe JZ, Vittinghoff E, Hopewell PC.

Clin Infect Dis. 2015 Mar 15;60(6):970. doi: 10.1093/cid/ciu1147. Epub 2014 Dec 19. No abstract available.

18.

Association between diabetes mellitus and tuberculosis in United States-born and foreign-born populations in San Francisco.

Suwanpimolkul G, Grinsdale JA, Jarlsberg LG, Higashi J, Osmond DH, Hopewell PC, Kato-Maeda M.

PLoS One. 2014 Dec 5;9(12):e114442. doi: 10.1371/journal.pone.0114442. eCollection 2014.

19.

Empiric tuberculosis treatment in retreatment patients in high HIV/tuberculosis-burden settings.

Metcalfe JZ, Mason P, Mungofa S, Sandy C, Hopewell PC.

Lancet Infect Dis. 2014 Sep;14(9):794-5. doi: 10.1016/S1473-3099(14)70879-5. No abstract available.

20.

Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

Davis JL, Kawamura LM, Chaisson LH, Grinsdale J, Benhammou J, Ho C, Babst A, Banouvong H, Metcalfe JZ, Pandori M, Hopewell PC, Cattamanchi A.

Am J Respir Crit Care Med. 2014 Jun 15;189(12):1551-9. doi: 10.1164/rccm.201311-1974OC.

21.

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.

Budzik JM, Jarlsberg LG, Higashi J, Grinsdale J, Hopewell PC, Kato-Maeda M, Nahid P.

PLoS One. 2014 Apr 23;9(4):e95645. doi: 10.1371/journal.pone.0095645. eCollection 2014.

22.

Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics.

Hopewell PC, Fair EL, Uplekar M.

Ann Am Thorac Soc. 2014 Mar;11(3):277-85. doi: 10.1513/AnnalsATS.201401-004AR.

PMID:
24673691
23.

Updating the international standards for tuberculosis care.

Hopewell PC.

Int J Tuberc Lung Dis. 2014 Mar;18(3):253. doi: 10.5588/ijtld.14.0035. No abstract available.

PMID:
24670556
24.

Drug-resistant tuberculosis in high-risk groups, Zimbabwe.

Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P.

Emerg Infect Dis. 2014 Jan;20(1):135-7. doi: 10.3201/eid2001.130732.

25.

Household catastrophic payments for tuberculosis care in Nigeria: incidence, determinants, and policy implications for universal health coverage.

Ukwaja KN, Alobu I, Abimbola S, Hopewell PC.

Infect Dis Poverty. 2013 Sep 17;2(1):21. doi: 10.1186/2049-9957-2-21.

26.

The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria.

Ukwaja KN, Alobu I, Lgwenyi C, Hopewell PC.

PLoS One. 2013 Aug 27;8(8):e73134. doi: 10.1371/journal.pone.0073134. eCollection 2013.

27.

We help the world breathe.

Hopewell PC.

Ann Am Thorac Soc. 2013 Aug;10(4):357-8. doi: 10.1513/AnnalsATS.201306-193ED. No abstract available.

PMID:
23952855
28.

Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.

Prach LM, Pascopella L, Barry PM, Flood J, Porco TC, Hopewell PC, Metcalfe JZ.

AIDS. 2013 Oct 23;27(16):2615-22. doi: 10.1097/01.aids.0000432445.07437.07.

29.

Tuberculosis and HIV co-infection, California, USA, 1993–2008.

Metcalfe JZ, Porco TC, Westenhouse J, Damesyn M, Facer M, Hill J, Xia Q, Watt JP, Hopewell PC, Flood J.

Emerg Infect Dis. 2013 Mar;19(3):400-6.

30.

Sublineages of lineage 4 (Euro-American) Mycobacterium tuberculosis differ in genotypic clustering.

Anderson J, Jarlsberg LG, Grindsdale J, Osmond D, Kawamura M, Hopewell PC, Kato-Maeda M.

Int J Tuberc Lung Dis. 2013 Jul;17(7):885-91. doi: 10.5588/ijtld.12.0960.

PMID:
23743309
31.

Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak.

Kato-Maeda M, Ho C, Passarelli B, Banaei N, Grinsdale J, Flores L, Anderson J, Murray M, Rose G, Kawamura LM, Pourmand N, Tariq MA, Gagneux S, Hopewell PC.

PLoS One. 2013;8(3):e58235. doi: 10.1371/journal.pone.0058235. Epub 2013 Mar 5.

32.

Molecular epidemiology of tuberculosis in foreign-born persons living in San Francisco.

Suwanpimolkul G, Jarlsberg LG, Grinsdale JA, Osmond D, Kawamura LM, Hopewell PC, Kato-Maeda M.

Am J Respir Crit Care Med. 2013 May 1;187(9):998-1006. doi: 10.1164/rccm.201212-2239OC.

33.

Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis.

Davis JL, Cattamanchi A, Cuevas LE, Hopewell PC, Steingart KR.

Lancet Infect Dis. 2013 Feb;13(2):147-54. doi: 10.1016/S1473-3099(12)70232-3. Epub 2012 Oct 23. Review.

34.

Evolution and revolution: the formation of today's American Thoracic Society, part 1.

Murray JF, Du Melle F, Hopewell PC.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):948-52. doi: 10.1164/rccm.201206-1004PP. Epub 2012 Jul 19.

PMID:
22822021
35.

Evolution and revolution: the formation of Today's American Thoracic Society, Part 2.

Hopewell PC, Du Melle F, Murray JF.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1082-6. doi: 10.1164/rccm.201206-1005PP. Epub 2012 Jul 19.

PMID:
22822018
36.

Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig.

Kato-Maeda M, Shanley CA, Ackart D, Jarlsberg LG, Shang S, Obregon-Henao A, Harton M, Basaraba RJ, Henao-Tamayo M, Barrozo JC, Rose J, Kawamura LM, Coscolla M, Fofanov VY, Koshinsky H, Gagneux S, Hopewell PC, Ordway DJ, Orme IM.

Clin Vaccine Immunol. 2012 Aug;19(8):1227-37. doi: 10.1128/CVI.00250-12. Epub 2012 Jun 20.

37.

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.

Dantes R, Metcalfe J, Kim E, Kato-Maeda M, Hopewell PC, Kawamura M, Nahid P, Cattamanchi A.

PLoS One. 2012;7(5):e37956. doi: 10.1371/journal.pone.0037956. Epub 2012 May 23.

38.

Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.

Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC, Pai M.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1120-9. doi: 10.1093/infdis/jir410. Review.

39.

Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis.

Steingart KR, Flores LL, Dendukuri N, Schiller I, Laal S, Ramsay A, Hopewell PC, Pai M.

PLoS Med. 2011 Aug;8(8):e1001062. doi: 10.1371/journal.pmed.1001062. Epub 2011 Aug 9. Review.

40.

Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study.

Nahid P, Horne DJ, Jarlsberg LG, Reiner AP, Osmond D, Hopewell PC, Bibbins-Domingo K.

Clin Infect Dis. 2011 Aug 1;53(3):291-4. doi: 10.1093/cid/cir378. Erratum in: Clin Infect Dis. 2011 Dec;53(11):1172.

41.

Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services.

Davis J, Katamba A, Vasquez J, Crawford E, Sserwanga A, Kakeeto S, Kizito F, Dorsey G, den Boon S, Vittinghoff E, Huang L, Adatu F, Kamya MR, Hopewell PC, Cattamanchi A.

Am J Respir Crit Care Med. 2011 Aug 1;184(3):362-7. doi: 10.1164/rccm.201012-1984OC. Epub 2011 Mar 11.

42.

Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review.

Steingart KR, Jotblad S, Robsky K, Deck D, Hopewell PC, Huang D, Nahid P.

Int J Tuberc Lung Dis. 2011 Mar;15(3):305-16. Review.

PMID:
21333096
43.

Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes.

Kato-Maeda M, Gagneux S, Flores LL, Kim EY, Small PM, Desmond EP, Hopewell PC.

Int J Tuberc Lung Dis. 2011 Jan;15(1):131-3.

44.

Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell PC, Pai M.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8. doi: 10.1097/QAI.0b013e31820b07ab. Review.

45.

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL.

BMC Infect Dis. 2011 Jan 3;11:1. doi: 10.1186/1471-2334-11-1.

46.

Integrated strategies to optimize sputum smear microscopy: a prospective observational study.

Cattamanchi A, Huang L, Worodria W, den Boon S, Kalema N, Katagira W, Byanyima P, Yoo S, Matovu J, Hopewell PC, Davis JL.

Am J Respir Crit Care Med. 2011 Feb 15;183(4):547-51. doi: 10.1164/rccm.201008-1207OC. Epub 2010 Sep 17.

47.

Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007.

Metcalfe JZ, Kim EY, Lin SY, Cattamanchi A, Oh P, Flood J, Hopewell PC, Kato-Maeda M.

Emerg Infect Dis. 2010 Sep;16(9):1403-9. doi: 10.3201/eid1609.100253.

48.

Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients.

Worodria W, Davis JL, Cattamanchi A, Andama A, den Boon S, Yoo SD, Hopewell PC, Huang L.

Eur Respir J. 2010 Aug;36(2):446-8. doi: 10.1183/09031936.00010210. No abstract available.

49.

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, Nahid P, Steingart KR.

Lancet Infect Dis. 2010 Jun;10(6):387-94. doi: 10.1016/S1473-3099(10)70071-2. Review.

50.

Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; Tuberculosis Trials Consortium.

PLoS One. 2010 May 20;5(5):e10753. doi: 10.1371/journal.pone.0010753.

Supplemental Content

Loading ...
Support Center